STOCKS TELEGRAPH

Author: Shimrez Hyder

  • Spi Energy Co. Ltd. (SPI) Stock Exhibits Minor Volatility Following Launch of Solar4America Amazon Store

    Spi Energy Co. Ltd. (SPI) stock prices were down by 4.31% as of the market closing on September 3rd, 2021. This brought the price per share down to USD$5.11 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rally by 4.89%, bringing it up to USD$5.36.

    SPI Stock Launches Solar4America

    The global renewable energy company and provider of solar storage and electric vehicle (EV) solutions announced the launch of its new Solar4America Amazon Store for Solarjuice Technology on September 7th 2021. This development will facilitate the provision of a myriad of Solar4America-branded off-grid solar products, portable battery power supply solutions and other consumer oriented mobile power devices.

    Ahead of the Competition

    SPI stock’s portable power supply supports PD 2.0 for 32% faster power delivery as compared to traditional methods. The products use innovative safety technology that boosts the overall safety rating for using a lithium-ion battery in a portable power station. the company’s devices are safer and last longer than their competitors’ power supplies due to multiple layers of built-in hardware protection, in addition to the aforementioned features. Furthermore, each power supply has a compact power inverter built into it that facilitates peak performance along with the company’s patented safety systems.

    Scope of SPI Stock’s Amazon Launch

    The company’s new e-commerce platform in collaboration with Amazon will facilitate SPI stock’s potential exposure and servicing of more customers. The company is allocating resources towards the expansion of the product portfolio for Solar4America. This is one of the ongoing efforts to build a complete ecosystem for green energy products and services. In conjunction with the company’s offline services and installations fleets across the U.S, their online services will be a one-stop shop for customers with green energy application needs.

    About Solarjuice

    Solarjuice is a leader in renewable energy systems solutions for both residential and small commercial markets. It has been a one-stop global solution for solar panels, inverters, and battery systems since its inception in 2009, over which it has served more than 400 customers and 3,000 B2B accounts. The company expects to facilitate the growth of its supply chain while enhancing its technology platform, as well as pushing for the expanded product delivery throughout the Asia Pacific Region and the North America markets.

    Future Outlook for SPI Stock

    SPI stock has reported a promising start to the second half of the fiscal year 2021, as evidence by its recent launch of the new Amazon store. The company is poised to capitalize on the opportunities afforded by its foray into the burgeoning e-commerce market. Investors are hopeful that this will facilitate consistent increases in shareholder value over the long term.

  • PhaseBio Pharmaceuticals Inc. (PHAS) Stock Exhibits Minor Volatility as Hospitals Maintain Maximum Capacities During Pandemic

    PhaseBio Pharmaceuticals Inc. (PHAS) stock prices were down by 2.11% as of the market closing on September 3rd, 2021. This brought the price per share down to USD$3.25 at the end of the trading day before the long weekend.

    PHAS stock’s Phase 3 REVERSE-IT Trial

    August 2021 saw PHAS stock announce the completion of the enrollment of its first 143 patients in the pivotal Phase 3 REVERSE-IT trial. The trial is for the company’s lead product candidate, bentracimab. 138 of the total patients enrolled required urgent surgery or an invasive procedure, with 5 patients reporting uncontrolled major or life-threatening bleeding. The clinical study is forecasted to enroll roughly 200 major bleeding or urgent surgery patients across global sits in the United States, Canada, the European Union, and China.

    PHAS Stock’s Phase 2b Bentracimab Trial

    PHAS stock announced the completion of enrollment in its Phase 2b trial of bentracimab in the same month. The randomized, double-blind, placebo-controlled trial enrolled 200 healthy older and elderly subjects on dual antiplatelet therapy of ticagrelor and low-dose aspirin. 150 of the total patients were randomized to receive the treatment, with reversal of the antiplatelet effects of ticagrelor. This primary endpoint for the trial was measured by the VerifyNow PRUTest biomarker.

    Chinese Approval of Bentracimab

    The company concurrently announced the approval of an Investigational New Drug application for bentracimab to the Center for Drug Evaluation of the China National Medical Products Administration. This move was executed in collaboration with the company’s developmental partner, SFJ Pharmaceuticals. The partners expect enrolling the first patients across sites in China by later 2021. This development has been funded by collaborative financing activity in January of 2020.

    EU Licensing Agreement with Alfasigma

    June 2021 saw PHAS stock announce an exclusive licensing agreement with Alfasigma for the commercialization of bentracimab. As per the agreement, the company will receive a USD$20 million upfront payment. This will be followed up by up to USD$25 million in pre-revenue regulatory milestones that the company will be eligible for, as well as up to USD$190 million in payments contingent upon the achievement of certain sales milestones.

    Future Outlook for PHAS Stock

    The company reported a promising quarter, consolidated by its financial reports for Q2 2021. PHAS stock is poised to capitalize on the opportunities afforded to it as a result of its quarterly developments. Current and potential investors are hopeful that management will be able to leverage the resources at their disposal. This is hoped to facilitate significant and sustained increases in shareholder value.

  • Synlogic Inc. (SYBX) Stock Surges Following Continued Momentum of Q2 2021 Financial Reports

    Synlogic Inc. (SYBX) stock prices were up by 17.78% some time after market trading commenced on September 3rd, 2021. This brought the price per share up to USD$3.18 early on in the trading day.

    Q2 2021 Financials

    The end of the second quarter of fiscal 2021 saw SYBX stock report a solid liquidity position. The company had cash, cash equivalents, and short-term investments in the amount of USD$115.5 million as of June 30th 2021. Q2 2021 saw the company report a consolidated net loss of USD$14.5 million, representing a net loss of USD$0.28 per share. This is comparable to a consolidated net loss of USD$15.5 million, which comes out to USD$0.44 per share, for the prior-year period.

    R&D and G&A Costs

    Research and development costs for the second quarter of fiscal 2021 were down to USD$10.7 million. Comparable R&D costs for the prior-year period came out to USD$12.9 million. General and Administrative expenses for the 2021 quarter, ended June 30th, 2021, came out to USD$4.1 million. This is compared to the USD$3.5 million reported for the second quarter of fiscal 2020.

    SYBX Stock’s Collaboration with Roche

    SYBX stock reported revenue in the amount of USD$0.2 million for the quarter ended June 30th, 2021, as compared to the USD$0.4 million reported for the prior-year period. Revenues for the 2021 quarter were generated in collaboration with Roche, for the discovery of a new Synthetic Biotic medicine for the treatment of IBD. As per the agreement, the partnering companies will collaborate to develop a Synthetic Biotic medicine that will address an undisclosed novel target in inflammatory bowel disease. Revenues for the 2020 quarter were due to the previous collaboration with AbbVie, which was terminated in May 2020.

    SYBX Stock’s Partnership with Gingko

    The company continues to advance its long-term strategic platform collaboration with Gingko Bioworks. This partnership facilitates the provision of an expanded synthetic biology capability for SYBX stock. This is a result of multiple undisclosed metabolic programs that are currently in the preclinical stages of development. April 2021 saw the company complete an underwritten public offering of 11.5 million shares, generating roughly USD$32.6 million in the capital.

    Future Outlook for SYBX Stock

    SYBX stock reported a promising quarter, consolidated by the strength of its financial reports for the second quarter of fiscal 2021. The company is poised to capitalize on the momentum generated over the course of the first half of the fiscal year. Current and potential investors are hopeful that management will be able to leverage the resources at their disposal. This is hoped to facilitate significant and sustained increases in shareholder value.

  • Neonade Inc. (NEON) Stock Surges as TSM Sales Continue Proliferating Global Markets

    Neonade Inc. (NEON) stock prices were up by 18.38% some time after market trading commenced on September 3rd, 2021. This brought the price per share up to USD$6.12 early on in the trading day.

    NEON Stock’s TSMs

    The second quarter of the fiscal year 2021 saw NEON stock continue to execute its strategies and further develop its business pipeline. The company continues to allocate resources towards contactless touch solutions for elevators and kiosks. This will be facilitated by the company’s proprietary Touch Sensor Modules which will offer an intuitive and safer user experience.

    Strength of Asian Market

    The company forecasted the first adopters of its TSM solutions to be based in Asia, with Q1 and Q2 2021 sales confirming these expectations. More than 70% of the company TSM sales over the first half of fiscal 2021 were made to Asian customers. These customers use the TSMs for contactless touch applications.

    Further Developments

    NEON stock also has several development and pilot projects in the works for elevators. The company is also facilitating an array of different public space kiosks across Asia. These will include self check-in and retail self-check-out kiosks. Asian customers are the company’s leading demographic, but NEON is continuing to see an increase in interest from European customers and North Americans. The company also continued to allocate resources towards recruiting a talented and experienced workforce across its sales, marketing, and engineering. This will serve to strengthen the team and help the company create and capitalize on growing market opportunities. These opportunities include both contactless touch opportunities with elevator kiosk customers, as well as other opportunities. Combined, these will allow the company to leverage its extensive IP portfolio.

    NEON Stock’s Revenue Report

    The second quarter of fiscal 2021 saw net revenues increase by 127% as compared to the prior-year quarter. This year-over-year difference is largely attributable to higher license revenues in Q2 2021. The yearly increase was further consolidated by higher revenues from the sale of Touch Sensor Modules. Partially offsetting these gains was a decrease in non-recurring engineering revenues.

    Future Outlook for NEON Stock

    NEON stock reported a stellar quarter, as evidenced by the strength of its financial reports for the second quarter of fiscal 2021. The company is poised to capitalize on the opportunities afforded to it as it ushers in unprecedented growth. Investors are confident in management’s ability to facilitate consistent gains in shareholder value over the long term.

  • Impel Neuropharma Inc. (IMPL) Stock Surged Following FDA Approval for TRUDHESA

    Impel Neuropharma Inc. (IMPL) stock prices surged by 21.15% shortly after market trading commenced on September 3rd, 2021. This brought the price per share up to USD$28.01 early on in the trading day.

    FDA Approval for IMPL Stock

    September 3rd, 2021 saw IMPL stock announce that the United States Food and Drug Administration approved TRUDHESA. TRUDHESA nasal spray has been approved for the acute treatment of migraine with or without aura in adults. The treatment was previously known as INP104. TRUDHESA makes use of Impel’s proprietary Precision Olfactory Delivery (POD) technology, thereby facilitating the gentle delivery of DHE to the bloodstream. The proven, well-established therapeutic access the bloodstream through the vascular-rich upper nasal space.

    About TRUDHESA

    TRUDHESA bypasses the gut and potential absorption issues, facilitating rapid, sustained, and consistent symptom relief. This is without the need for injection or infusion, even when administered several hours after the onset of a migraine attack. The commercial launch of the treatment is scheduled for early October 2021.

    Scope of TRUDHESA

    The company is keen to leverage the approval of TRUDHESA as it offers millions of Americans with migraines a non-oral, acute treatment option. This solution is hoped to provide rapid, sustained, and consistent relief, even when administered late into a migraine attack. The treatment’s approval marks the culmination of more than a decade of research and advanced engineering that has resulted in the pairing of the proven efficacy of DHE with our innovative POD technology.

    IMPL Stock’s STOP 301 study.

    IMPL stock’s New Drug Application for TRUDHESA included the results of STOP 301. The Phase 3 open-label, pivotal safety study is the largest longitudinal study ever conducted with DHE using nasal spray delivery. The study saw 5,650 migraine attacks being treated over 24 or 52 weeks. The primary objective of the study is to assess the safety and tolerability of TRUDHESA. Exploratory objectives were comprised of efficacy assessments of migraine measures and a patient acceptability questionnaire. TRUDHESA was generally well tolerated during the trial, with exploratory efficacy findings showing the facilitating rapid, sustained, and consistent symptom relief.

    Future Outlook for IMPL Stock

    The company reported a strong quarter, as evidenced by the strength of its financial reports for the quarter. IMPL stock is poised to capitalize on the opportunities presented to it as it gears up for the second half of the fiscal year. Current and potential investors are hopeful that management will be able to usher in organic growth over the long term.

  • Ooma Inc. (OOMA) Stock Surges Following Disclosure of Promising Financial Reports for Q2 2022

    Ooma Inc. (OOMA) stock prices were up 8.06% around market trading commencing on September 3rd 2021. This brought the price per share up to USD$21.32 early on in the trading day.

    OOMA Stock Revenue Reports

    Revenues for the second quarter of fiscal 2022 came out to USD$47.1 million, representing a 14% year over year increase. Subscriptions and services revenue was up to USD$43.5 million for the second quarter of fiscal 2022. This is comparable to the USD$38.5 million in the prior year quarter. This year over year difference was largely driven by the growth of the Ooma Business, resulting in subscription and services revenue accounting for 93% of total revenue for Q2 2022.

    GAAP Net Loss/Income

    GAAP net loss for the fiscal 2022 quarter came out to USD$0.4 million, which represents a GAAP net loss of USD$0.02 per basic and diluted share. This is the same as GAAP net loss reports for the prior year quarter. Non-GAAP net income came out to USD$3.3 million for the second quarter of fiscal 2022, representing a net income of USD$0.13 per diluted share. This is comparable to a non-GAAP net income of USD$3.1 million for the prior year quarter, which represented a net income of USD$0.13 per diluted share.

    Continued Trajectory of Success

    The strength of the fiscal quarter built on the improvement of several key metrics across the business. Revenues were up sequentially to 26% year over year, coming out to an expanded 48% of total revenue. OOMA stock continued allocating resources towards executing its leadership strategy, as it developed its enterprise business solutions and facilitated global expansion. The company is confident that the momentum generated will be adequately carried forward through the upcoming quarters.

    OOMA Stock’s Guidance

    Based on the positive results, OOMA stock expects total revenue in the range of USD$47.8 million to USD$48.5 million for the third quarter of fiscal 2021. GAAP net loss is forecasted to be in the range of USD$0.8 million to USD$1.6 million, while GAAP net loss per share coming out to USD$0.04 to USD$0.07 per share.

    Future Outlook for OOMA Stock

    OOMA stock reported a promising quarter, as evidenced by the strength of its financial reports for the second quarter of fiscal 2022. The company is keen to leverage the resources at its disposal in a bid to continue their trajectory of success. Current and potential investors are hopeful that management will be able to facilitate significant and sustained increases in shareholder value.

  • Navios Maritime Holdings Inc. (NM) Stock Trends Lower Following Disclosure of Financial Reports for Q2 2021

    Navios Maritime Holdings Inc. (NM) stock prices were down by 1.51% as of the market closing on September 2nd, 2021. This brought the price per share down to USD$5.88 at the end of the trading day. Subsequent premarket fluctuations have seen the stock fall by 2.21%, bringing it down to USD$5.750.

    NM Stock’s Collaboration

    August 26th, 2021 saw NM stock announce a definitive transaction agreement with Navios Partners. The transaction will facilitate the combination of the two companies, after which public shareholders of the combined company will receive compensation. Each shareholder will receive 0.1275 stock of Navios Partners for each outstanding common share of Navios Acquisition.

    Details of the Transaction

    Accordingly, the entirety of Navios Acquisition’s outstanding 8.125% First Priority Ship Mortgage Notes are being redeemed, despite being due on November 15th 2021. This redemption is in accordance with the terms with the proceeds of a cash contribution from Navios Partners. A newly arranged secured term loan financing option is also contributing to the move. The closing of the merger is expected for the fourth quarter of 2021, after which Navios Holdings expects a 10.3% ownership interest in Navios Partners.

    NM Stock’s Vessel Sales

    June 2021 saw NM stock agree to sell the Navios Azimuth, Navios Bonavis, and the Navios ray to Navios Partners. The aggregate sales price of the vessels came out to a total of USD$88 million. The 179,169 dwt 2011 Capesize vessel, Azimuth, was sold off in a transaction dated July 2021. The 179,515 dwt 2021 Capesize vessel, Navios Bonavis, and the 180.022 dwt 2009 Capesize vessel, Navios Ray were both sold in a transaction dated June 2021.

    Q2 2021 Financials

    The second quarter of fiscal 2021 reported promising results. NM stock reported revenues in the amount of USD$143.6 million, along with Adjusted EBITDA in the amount of USD$85.9 million. Adjusted net income for the quarter came out to USD$30.3 million. These strong figures reflect the strength of the dry bulk market. The strength of the market is supported by rates across different vessel types. Capesize rates averaged USD$50,000 per day, while Panamax and Supramax raked in USD$35,000 a day.

    Future Outlook for NM Stock

    Q2 2021 proved to be a highly encouraging quarter for NM stock, as evidenced by the strength of its financial reports. Current and potential investors are excited to see the company effectively leverage the resources at their disposal to drive organic growth. This is hoped to facilitate significant and sustained increases in shareholder value.

  • Liquid Media Group Ltd. (YVR) Stock Exhibits Volatility Following Execution of iNDIEFLIX Acquisition

    Liquid Media Group Ltd. (YVR) stock prices were up by 12.02% as of the market closing on September 2nd, 2021. This brought the price per share up to USD$2.05 at the end of the trading day. Subsequent premarket fluctuations have seen the stock dip by 6.34%, bringing it down to USD$1.92.

    YVR Stock Acquires iNDIEFLIX

    September 2nd, 2021 saw YVR stock announce the execution of a definitive agreement with iNDIEFLIX Group. The agreement is set to see the global market leader in educational entertainment be acquired by Liquid. The all-stock transaction is expected to be completed in the upcoming days as the last of the customary closing conditions are fulfilled. The move marks a landmark acquisition for the company as it works to support independent creative professionals and IP owners in monetizing their content. Besides the previous substantial benefits to producers of purposeful content, iNDIEFLIX has the potential to assist the company in driving growth over the long term.

    About iNDIEFLIX

    The global subscription video-on-demand streaming service is focused on content with a purpose. The service’s success in providing monetization opportunities for IP owners works on cohesion with the company’s mission to guide creatives go from inception to monetization. This complementary nature of the collaboration is hoped to result in a plethora of opportunities for the partners.

    YVR Stock’s Transaction Details

    As per the definitive agreement, YVR stock is set to acquire iNDIEFLIX for up to 2.5 million common shares of the company’s common stock. Each share will be priced at USD$2.00 per share and is scheduled to be disbursed to iNDIEFLIX investors over the course of specific performance milestones. Each of the five milestone will have an equal tranche of 500,000 common shares.

    Additional Details

    The first tranche of consideration shares is forecasted to be paid out upon the closing of the deal. The remaining four milestones will be triggered by iNDIEFLIX revenues totaling USD$65 million in the upcoming years. The partnering company is continuing to invest resources towards its ongoing operations, the first of which is a secured bridge loan of USD$500,000. This has been applied towards working capital and the production of original content for iNDIEFLIX education and other channels.

    Future Outlook for YVR Stock

    The company reported a strong quarter, topped off by its acquisition of iNDIEFLIX. With the added resources at its disposal and the momentum generated, YVR stock is keen to leverage these to usher in a continued trajectory of growth. Investors are hopeful that this will result in significant and sustained increases in shareholder value.

     

  • Data Storage Corp. (DTST) Stock Surges Following Announcement of Strategic Partnership with Precisely

    Data Storage Corp. (DTST) stock prices surged by 23.98% some time after market trading commenced on September 2nd, 2021. This brought the price per share up to USD$4.86 early on in the trading day.

    DTST Stock Partners with Precisely

    September 2nd 2021 saw DTST stock announce the establishment of a managed services model partnership with Precisely. The collaboration with the global leader in data integrity software is expected to bring innovative security software solutions to the company. The companies have previous maintained a partnership for several years within the traditional IBM mainframe environment. DTST is keen to offer Precisely data integrity solutions to the many companies migrating to the cloud. These companies exhibit a need for the protection of their information, data security, and compliance adherence.

    Harmonious Union

    The combination of the company’s expertise in IBM power systems and cloud solutions make the union a natural order of course with the highly complementary and robust security software solutions offered by Precisely. DTST stock’s ezSecurity is a graduated menu of IT security offerings that are focused on customer needs. The service starts with a security risk assessment that is free of charge.

    Scope of Collaboration

    The addition of the partnering company’s expanded solutions within a cloud environment facilitates the provision of a more robust and full-featured, monthly subscription-based offering. This service serves to address the most common IT security exposure issues, including ransomware. The free risk assessment and associated reports are designed to pinpoint challenges and immediately rectify any issues that are uncovered.

    DTST Stock’s Market Leadership

    DTST stock was a pioneer in cloud-based computing for IBM power systems. It managed this with the use of efficient, shared, and scalable resources architecture that served to mitigate costs of equipment and administrative overhead. Furthermore, the company has developed a unique portfolio of accessible branded solutions that are quick to deploy, cover high availability, disaster recover, and full-production hosting. All of these features are coupled with managed services expertise.

    Future Outlook for DTST Stock

    The company reported a stellar quarter, evidenced by the strength of its financial reports and consolidated by its partnership with Precisely. DTST stock is poised to capitalize on the expanded scope of opportunities afforded to it as a result of its new collaboration. Current and potential investors are hopeful that management will be able to leverage the resources at its disposal. This is, in turn, hoped to facilitate significant and sustained increases in shareholder value.

  • Phreesia Inc. (PHR) Stock Dipped Following Disclosure of Financial Reports for Q2 2021

    Phreesia Inc. (PHR) stock prices were down by 10.90% some time after market trading commenced on September 2nd, 2021. This brought the price per share down to USD$61.87 early on in the trading day.

    PHR Stock Reports Strong Q2 2022

    Revenue for the second quarter of fiscal 2022 was reported at USD$51 million. This is a 46% year-over-year increase from the USD$35 million in Q2 fiscal 2021. The average number of provider clients was up 19% for the second quarter of fiscal 2022. The fiscal 2022 quarter reported 1,987 average number of provider clients, up from 1,668 in Q2 of fiscal 2021.

    Additional Financials

    Average revenue per provider client for the second quarter of fiscal 2022 came out to USD$19,720. This is a 14% year-over-year increase from the USD$17,360 reported for Q2 of fiscal 2021. Adjusted EBITDA suffered, with the fiscal 2022 quarter coming in at negative USD$11 million. This is up from the Adjusted EBITDA of positive USD$1.2 million in the prior-year quarter.

    PHR Stock’s Liquidity Position

    PHR stock reported ending the second quarter of fiscal 2022 with a solid liquidity position. The company reported having cash and cash equivalents in the amount of USD$439.9 million as of July 31st, 2021. This is a USD$221.1 million increase from the liquidity position reported as of January 31st, 2021. This difference is largely attributable to the follow-on offering of the company’s common stock, which generated net proceeds in the amount of USD$245.8 million. This increase was partially offset by cash used for operating activities, capital expenditures, and payments of finance leases and other debt.

    Increased Guidance

    Based on the strength of the second quarter of fiscal 2022, PHR stock increased its revenue outlook for the rest of fiscal 2022. Previous ranges of USD$191 million to USD$194 million were bumped up to USD$195 million to USD$198 million. The company expects overall cash outflow to increase in fiscal 2022 as compared to fiscal 2021. This will be a result of the ramping up of hiring and infrastructure across the organization.

    Future Outlook for PHR Stock

    The company reported a promising quarter, as evidenced by the strength of its financial reports for the second quarter of fiscal 2022. PHR stock is poised to capitalize on the opportunities afforded to it as it maintains the momentum it has generated over the quarter. Current and potential investors are hopeful that management will be able to facilitate consistent and organic growth in shareholder value over the long term.